advancing innovation to save lives

GHTC launches call for nominations for Innovating for Impact Awards

GHTC is seeking nominations for its new Innovating for Impact Awards initiative to celebrate the research partnerships and political champions that help transform breakthrough scientific research into lifesaving drugs, vaccines, and other health tools for unmet global health challenges. Nominations will be accepted through September 20, 2017
Learn More

Return on innovation

A new report from GHTC examines the impact of US government investment in global health R&D at home and abroad, from delivering lifesaving tools for the world’s most vulnerable people to generating economic and security returns for the United States.
 
Learn More

Medicines for Malaria Venture

Medicines for Malaria Venture works with partners to discover, develop and accelerate delivery of new antimalarial therapies. In partnership, it has built the largest-ever portfolio of antimalarial drug projects and brought forward seven new medicines that are estimated to have saved over a million lives to date.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Doune Porter
GHTC calls for US engagement in innovative effort to bring vaccines to children worldwide

GlaxoSmithKline and Pfizer today announced that they have joined the first Advance Market Commitment (AMC), a unique funding effort to bring pneumococcal vaccines to millions of children worldwide. GHTC commends increased involvement in the AMC and calls on the United States to participate in innovative health financing mechanisms, including a future AMC, to maximize the life-saving potential of immunizations worldwide.

Learn More
PATH/Patrick McKern
GHTC applauds CSIS Commission report highlighting need for global health research, innovative financing

The Center for Strategic and International Studies (CSIS) today released the final report of its Commission on Smart Global Health Policy, providing recommendations for US policymakers on creating a long-term and strategic approach to global health. GHTC applauds the Commission’s inclusion of research and innovative financing among its recommendations for strengthening US global health programs, developing new products, and bolstering health systems overseas.

Learn More
View All News & Events

Community Event

United Nations
72nd Session of the UN General Assembly (UNGA 72)
United Nations
Learn More

Community Event

PATH/Gabe Bienczycki
The Role of the Private Sector in Advancing Global Health
CSIS
Learn More
View All Events
PATH/Gabe Bienczycki
Research Roundup: Technology to save mothers, an all-inclusive vaccine, and malaria's relationship with carbohydrates

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Andrew Berends
Research Roundup: Zika vaccine dead ends, an Ebola data-sharing platform, and a low-cost newborn asphyxia treatment

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide